Cell BiologybioRxivPreprint
Polycomb Repressive Complex 2 promotes atherosclerotic plaque vulnerability
Divyesh Joshi, Raja Chakraborty, Tejas Bhogale…·Martin Alexander Schwartz
This study identifies PRC2 as a driver of atherosclerosis by suppressing Klf2/4, and shows that inhibiting PRC2 with tazemetostat reduces plaque progression and improves stability.
2 citations